Recurrence of high-risk bladder cancer: a population-based analysis.
about
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted TherapyTreatment options in non-muscle-invasive bladder cancer after BCG failureInvolvement of the Androgen and Glucocorticoid Receptors in Bladder CancerFemale with bladder cancer: what and why is there a difference?A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer CellsNatural biology and management of nonmuscle invasive bladder cancer.Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.Predicting recurrence and progression of non-muscle-invasive bladder cancer in Korean patients: a comparison of the EORTC and CUETO models.Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancerAn anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder.The evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.Results of second transurethral resection for high-grade T1 bladder cancer.Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional StudySweet-P inhibition of glucocorticoid receptor β as a potential cancer therapy.Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience.Gender differences in incidence and outcomes of urothelial and kidney cancer.Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.Future directions in bladder cancer immunotherapy: towards adaptive immunity.Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature ReviewNext-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.SLC14A1: a novel target for human urothelial cancer.Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer.Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer.Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinomaEffects of increased Kindlin-2 expression in bladder cancer stromal fibroblastsNovel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancerIdentification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.[The relationship between tumor recurrence and polymorphisms of hGPX1 and NRAMP1 in superficial bladder cancer patients: a meta-analysis].Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2.Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse.Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research.Next-generation sequencing in non-muscle-invasive bladder cancer-a step towards personalized medicine for a superficial bladder tumor.Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer.The interplay between adipose-derived stem cells and bladder cancer cellsMicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21
P2860
Q21131727-6320DA67-53FD-40E8-B697-E047CF67FFFEQ26775977-B702D65B-655D-4306-AF93-572E36E24555Q26782760-7EF59931-B53C-49FD-8411-CCAA04A67002Q28066115-2ED81615-E702-431B-A0FA-7D065D60757FQ32183014-3F8A3179-34E1-42CB-8861-153BF6D6EB8DQ33561637-A573828E-450C-408D-914B-5649FF795FD0Q33994334-C57F05A8-FF01-4528-B4A7-4224049161D8Q34346848-F962B710-E954-41D2-B4CB-391DC263EF4DQ34758436-7C864661-65D0-4731-9C41-7BAFCC7DBDCBQ35151905-B6EB80D5-A6A3-4D21-B7C1-A36B4C4A5F2AQ35300254-BC8F4500-CB6A-4D84-A8C5-135804749641Q35630898-0FB3A720-2719-4677-8A3D-C3DBDF7D7E37Q36356414-6EC56034-A37A-4DC7-B357-AAE8F869F58FQ36481219-E95A14A6-A0D8-4051-A752-FE7466381765Q37053829-39D4D2EE-2246-456B-A7CA-F96222A2964AQ37110153-E09F6788-7917-4468-8170-771C4C5CFF43Q37123685-011535E7-46B5-4A13-901F-1BB70AE40CEFQ37616492-50330053-BC28-4A23-8905-0FD293931358Q38252737-91791B27-438D-40D5-BE0D-AAA54914A6D1Q38599201-9547348F-889B-47A9-AF45-7EE281E1639BQ38717980-C5AE8AB8-3FA4-4924-B266-BC1D91B24740Q38727522-6B54577F-11B6-44AD-AA33-A29802CF77AEQ39202070-A3E80BCC-0777-4126-A23B-70140D239ACEQ39352697-96A03C8D-4C23-43DF-BA42-88CFE4423B6FQ39356231-04581AB8-33FA-4C72-BE10-E01DFC0AF787Q39586831-0226803F-D538-449B-8299-59A810F1D52CQ40839403-29178FB4-2732-4C63-A024-BCFA2F45419AQ41279969-94F79E8E-8F5D-4472-8232-D1E217C76D3AQ41612367-5C0C1B4A-3359-44A0-8A6C-3C017B04B8B6Q41634313-C1A074D1-ABC2-40BF-B77A-26A7CC009EE7Q42290198-9CE542A9-5644-477A-8B35-F39D0B6DA730Q45927876-B79F1C31-0C28-4AA5-9B33-EBF84D98CF3BQ45980440-FA2C7136-7804-4B46-B9C0-82D3B88B2505Q47564539-2C9B0446-55A5-4D18-9FD1-05ED96D56168Q47669283-4C31C05E-6128-4B7D-811A-C90EB2FC9BB8Q49206807-A79F9419-1104-4DF5-84AB-45148343BE95Q50432407-B55A0BB6-82EE-4F89-B152-91560B166077Q55319024-28C84599-4E93-4D3B-B0E2-2CF5903BBC70Q57477138-FB26E9F1-C0A6-411C-BC2E-D6EBB05E5E1EQ58712586-775B1458-DC5F-43EE-8BEE-566D9FB5BB11
P2860
Recurrence of high-risk bladder cancer: a population-based analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recurrence of high-risk bladder cancer: a population-based analysis.
@en
Recurrence of high-risk bladder cancer: a population-based analysis.
@nl
type
label
Recurrence of high-risk bladder cancer: a population-based analysis.
@en
Recurrence of high-risk bladder cancer: a population-based analysis.
@nl
prefLabel
Recurrence of high-risk bladder cancer: a population-based analysis.
@en
Recurrence of high-risk bladder cancer: a population-based analysis.
@nl
P2093
P2860
P356
P1433
P1476
Recurrence of high-risk bladder cancer: a population-based analysis
@en
P2093
Badrinath R Konety
Christopher S Saigal
Jan M Hanley
Karim Chamie
Mark S Litwin
Timothy J Daskivich
Urologic Diseases in America Project
P2860
P304
P356
10.1002/CNCR.28147
P407
P577
2013-06-04T00:00:00Z